|
Series: Critical Concepts in Intellectual Property Law series
Description
‘Professor Carrier has done an excellent job of assembling the most significant scholarship on the intersection of intellectual property and competition laws. The major schools of thought are fairly represented. This volume is comprehensive and includes both the essential foundational work in this field as well as recent influential commentaries on the latest controversies, including patent pools, refusals to license, and reverse settlements in pharmaceutical patent litigation.’ – Christopher R. Leslie, University of California – Irvine, US
Contents
14 articles, dating from 1966 to 2008
Contributors include: W. Baxter, H. Hovenkamp, L. Kaplow, M. Lemley, R. Merges, R. Pitofsky, R. Posner, A. Rai, C. Scott Hemphill, C. Shapiro
Further information
Full table of contents
Contents:
Acknowledgements
Introduction Michael A. Carrier
PART I HISTORY 1. Herbert Hovenkamp (2005), ‘The Conflict Between Antitrust and Intellectual Property Rights’
PART II NEW ECONOMY 2. Richard A. Posner (2001), ‘Exclusionary Practices (II): The New Economy’ 3. Robert Pitofsky (2001), ‘Antitrust and Intellectual Property: Unresolved Issues at the Heart of the New Economy’
PART III GLOBAL APPROACHES 4. William F. Baxter (1966), ‘Legal Restrictions on Exploitation of the Patent Monopoly: An Economic Analysis’ 5. Ward S. Bowman, Jr. (1973), ‘The Compatibility of Antitrust and Patent Law Goals’ 6. Louis Kaplow (1984), ‘The Patent-Antitrust Intersection: A Reappraisal’ 7. Michael A. Carrier (2002), ‘Unraveling the Patent-Antitrust Paradox’
PART IV SPECIFIC ACTIVITY 8. Herbert Hovenkamp, Mark D. Janis and Mark A. Lemley (2006), ‘Unilateral Refusals to License’ 9. Carl Shapiro (2000), ‘Navigating the Patent Thicket: Cross Licenses, Patent Pools, and Standard Setting’ 10. Robert P. Merges (2001), ‘Institutions for Intellectual Property Transactions: The Case of Patent Pools’ 11. Michael A. Carrier (2008), ‘Two Puzzles Resolved: Of The Schumpeter – Arrow Stalemate and Pharmaceutical Innovation Markets’ 12. Arti K. Rai (2001), ‘Fostering Cumulative Innovation in the Biopharmaceutical Industry: The Role of Patents and Antitrust’ 13. Mark A. Lemley (2002), ‘Intellectual Property Rights and Standard-Setting Organizations’ 14. C. Scott Hemphill (2006), ‘Paying for Delay: Pharmaceutical Patent Settlement as a Regulatory Design Problem’
|